Company Filing History:
7 out of 13 
3 out of 3 
2 out of 7 
Years Active: 2017-2025
Title: Lihua Jiang: Pioneering Innovations in Pharmaceutical Research
Introduction
Lihua Jiang, an innovative inventor based in Chongqing, China, has made significant contributions to the field of pharmaceutical research. With a portfolio consisting of 10 patents, he specializes in developing novel compounds with therapeutic applications, particularly in the area of kinase inhibitors and apoptosis-inducing agents.
Latest Patents
Among Lihua Jiang's latest patents is a focused advancement in the form of substituted 2-azabicyclo[3.1.0]hexanes, which serve as TRK kinase inhibitors. This patent includes pharmaceutical compositions and methods for their use, highlighting his commitment to addressing critical health challenges. In addition, he has developed apoptosis-inducing agents, featuring specific Bcl-2 inhibitors along with their corresponding pharmaceutical compositions and applications, demonstrating his dedication to cancer research and drug development.
Career Highlights
Lihua Jiang's professional journey has seen him contribute his expertise to prominent organizations. He has worked with Shanghai Fochon Pharmaceutical Co., Ltd. and Chongqing Fochon Pharmaceutical Co., Ltd., where he participated in cutting-edge research and development projects. His strong focus on innovation has positioned him as a key player in the advancement of pharmaceutical sciences.
Collaborations
Throughout his career, Lihua Jiang has collaborated with esteemed colleagues such as Xingdong Zhao and Weibo Wang, a talented woman who shares his passion for scientific discovery. These collaborations have further enriched his research endeavors, leading to groundbreaking inventions and advancements in drug therapies.
Conclusion
Lihua Jiang's innovative spirit and dedication to improving health outcomes through his patent portfolio exemplify the transformative impact of inventors in the pharmaceutical industry. As he continues to make strides in his research, his contributions pave the way for new therapeutic solutions that may one day benefit countless patients worldwide.